首页> 外国专利> COMPOSITIONS AND METHODS FOR CANCER MANAGEMENT USING ANTIBODIES BINDING TO NUCLEOTIDE SALVAGE PATHWAY ENZYMES AND COMPLEXES THEREOF

COMPOSITIONS AND METHODS FOR CANCER MANAGEMENT USING ANTIBODIES BINDING TO NUCLEOTIDE SALVAGE PATHWAY ENZYMES AND COMPLEXES THEREOF

机译:使用与核苷酸拯救途径酶结合的抗体进行癌症治疗的组合物和方法,并使其复杂化

摘要

Compositions and methods are provided for the diagnosis, treatment, and medical management of cancers. The methods include the use of antibodies and other binding molecules that specifically bind to one or more nucleotide salvage pathway enzymes (SPEs) selected from the group consisting of adenine phosphoribosyltransferase (APRT), hypoxanthine-guanine phosphoribosyltransferase (HGPRT), deoxycytidine kinase (dCK); and thymidine kinase 1 (TK1 ) and complexes comprising SPEs, for detection of the SPE(s) on or in cancer cells and/or on or in body fluids and tissues of cancer patients. Binding of SPEs is useful in the methods provided herein for diagnosing cancer, determining prognosis of cancer and assessing the effectiveness of cancer treatments. Immunoassay systems for use in the methods are also provided, including sandwich immunoassays. In addition, an amino acid sequence comprising a novel TK1 binding site is provided, as well as nucleotide sequences encoding it.
机译:提供了用于癌症的诊断,治疗和医学管理的组合物和方法。该方法包括使用与一种或多种核苷酸挽救途径酶(SPE)特异性结合的抗体和其他结合分子的使用,该酶选自腺嘌呤磷酸核糖基转移酶(APRT),次黄嘌呤-鸟嘌呤磷酸核糖基转移酶(HGPRT),脱氧胞苷激酶(dCK) ;以及胸苷激酶1(TK1)和包含SPE的复合物,用于检测癌细胞或癌症患者体液和组织中或体内的SPE。 SPE的结合可用于本文提供的方法中,用于诊断癌症,确定癌症的预后以及评估癌症治疗的有效性。还提供了用于该方法的免疫测定系统,包括夹心免疫测定。另外,提供了包含新的TK1结合位点的氨基酸序列以及编码它的核苷酸序列。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号